- Home
- CYN vs VTGN Comparison
CYN vs VTGN Comparison
Compare CYN & VTGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CYN | VTGN |
|---|---|---|
| Founded | 2013 | 1998 |
| Country | United States | United States |
| Employees | 62 | N/A |
| Industry | EDP Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 22.9M | 24.1M |
| IPO Year | 2021 | 2014 |
Fundamental Metrics
Financial Performance| Metric | CYN | VTGN |
|---|---|---|
| Price | $1.42 | $0.64 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $0.90 |
| AVG Volume (30 Days) | 273.8K | ★ 596.1K |
| Earning Date | 05-06-2026 | 06-16-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $368,138.00 | N/A |
| Revenue This Year | $3,359.28 | $124.49 |
| Revenue Next Year | $347.47 | $353.99 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $1.29 | $0.43 |
| 52 Week High | $41.54 | $5.14 |
Technical Indicators
Market Signals| Indicator | CYN | VTGN |
|---|---|---|
| Relative Strength Index (RSI) | 39.15 | 53.65 |
| Support Level | $1.33 | $0.63 |
| Resistance Level | $1.76 | $0.64 |
| Average True Range (ATR) | 0.08 | 0.05 |
| MACD | -0.01 | 0.00 |
| Stochastic Oscillator | 22.02 | 57.00 |
Price Performance
Historical ComparisonAbout CYN Cyngn Inc.
Cyngn Inc is an industrial autonomous vehicle technology company, focused on addressing industrial uses for autonomous vehicles. It develops full-stack autonomous driving software, DriveMod, which is integrated into vehicles manufactured by original equipment manufacturers during the assembly process. The company designs its software to be compatible with a range of sensors and hardware components and integrates it with its own systems to enable autonomous vehicle functionality.
About VTGN VistaGen Therapeutics Inc.
Vistagen Therapeutics Inc is a biotechnology firm. The company is neuroscience-focused biopharmaceutical company dedicated to pursuing a pioneering approach to the development and commercialization of groundbreaking therapies for psychiatric and neurological disorders based on deep understanding of nose-to-brain neurocircuitry.